Thank you to Cardiac Wire for sharing important news about innovation that is moving cardiology care forward! Check out "The Wire" and read about why hospitals, health systems, and physicians are relying on #vMap to address issues with efficiency and outcomes in the EP lab. https://lnkd.in/eFbMcxEV #eplab #healthsystems #healthcareoutcomes #innovation #cardiology
Vektor Medical, Inc.
Medical Equipment Manufacturing
San Diego, California 7,945 followers
On a mission to revolutionize arrhythmia care.
About us
Vektor Medical is on a mission to revolutionize arrhythmia care. The FDA-cleared vMap technology is an arrhythmia analysis tool developed with AI to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency.
- Website
-
http://www.vektormedical.com
External link for Vektor Medical, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- San Diego, California
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Atrial Fibrillation, Electrophysiology, Ablation, and aFib
Locations
-
Primary
San Diego, California, US
-
Seattle, Washington, US
Employees at Vektor Medical, Inc.
Updates
-
Why do the same, if you can do better? vMap is an arrhythmia analysis tool, created to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency. A better path forward in arrhythmia care. #vMap #healthcareinnovation #cardiology #eplab
-
vMap integrates seamlessly into existing systems, making it an increasingly valuable solution for electrophysiologists seeking greater efficiency and performance without compromise. #vMap #eplab #electrophysiology #medtech
-
-
Thank you for sharing our news Medical Device News Magazine! 🙏 #vMap #cardiology #EPLab #medtech
7/23/25: Vektor Medical, Inc. Medical Reports | vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care: Robert Krummen, CEO: “With every procedure, physicians are leveraging vMap’s rapid, non-invasive insights to make informed decisions and streamline care. We’re seeing growing demand quarter over quarter as both physicians and hospitals look for ways to enhance efficiency and elevate patient care.”
-
🙌 BIG MILESTONE. BIG IMPACT. 🙌 vMap surpasses 2,000 procedures, driving a new standard in arrhythmia care. Momentum is building — fast. Hospitals and EPs throughout the U.S. are using #vMap to transform how arrhythmias are understood and treated by leveraging rapid, non-invasive insights that can help: ✅ Improve procedural efficiency ✅ Reduce repeat interventions ✅ Support better outcomes “This milestone represents meaningful momentum. With every procedure, physicians are leveraging vMap’s rapid, non-invasive insights to make informed decisions and streamline care. We’re seeing growing demand quarter over quarter as both physicians and hospitals look for ways to enhance efficiency and elevate patient care.” — Robert J. Krummen, CEO of Vektor Medical, Inc. 👏 Press release + Dr. Anish Amin's perspective on vMap here: https://lnkd.in/gMx94iV5 Let's share this news and keep the momentum going! Message us to learn more about vMap or to schedule a demo. #Electrophysiology #cardiology #eplab #Arrhythmias #afib #medtech
-
“The IMPRoVED-AF study is an important validation of the meaningful impact vMap is already delivering in the EP lab. vMap is uncovering drivers that often go undetected, helping physicians deliver more effective and durable outcomes. This study is a critical part of our strategy to build the clinical evidence that drives confident adoption, supports value in health systems, and positions vMap as the new standard in arrhythmia care.” Robert J. Krummen CEO #medtech #eplab #clinicaldata #vMap
-
-
By unlocking insights from a standard 12-lead ECG, vMap helps physicians identify arrhythmia sources faster, reduce overall procedure times, and overcome limitations, enabling the successful treatment of complex arrhythmias For patients, that means fewer procedures, less hospital time, and more life lived. #vMap #medtech #cardiology #patientimpact
-
"BIGGER. BOLDER. MORE." That's how Good MedTech News describes the latest edition of the "MedTech Opinion Leader" magazine featuring a "dream team" of innovators driving medtech forward. 🙌 We're honored to see our CEO, Robert J. Krummen, featured alongside other trailblazers, sharing his perspective on what it really takes to bring meaningful innovation to cardiac care. 🙌 At Vektor, bold innovation isn't just about ambition; it's about accountability. As Rob shared in the article, "At Vektor, bold innovation is inseparable from clinical and regulatory discipline. vMap is the only FDA-cleared, non-invasive platform developed with AI to localize arrhythmia sources using a standard 12-lead ECG; a technical breakthrough grounded in years of rigorous development, clinical research, and regulatory oversight." That discipline is foundational to how we make things happen at Vektor. We develop, validate, and deploy innovation in ways that are simple to implement, clinically meaningful, and designed to drive better outcomes for patients, physicians, and health systems. Big thanks to MedTech Opinion Leader and Stan Kalinin for the opportunity to share what drives innovation at Vektor! And check out the full issue here with 🔥 Joe Mullings 🔥 on the cover: https://lnkd.in/gx4cE_rN #medtech #healthcareinnovation #boldinnovation #cardiology
-
Momentum continues to build at Vektor! �� The IMPRoVED-AF study is underway, and the response from the EP community has been remarkable. This prospective, randomized, multi-center study will evaluate how vMap, the only FDA-cleared non-invasive arrhythmia analysis technology designed to improve, enhance, and accelerate ablation procedures, utilizing data from a standard 12-lead ECG, can support more effective ablation strategies in persistent and recurrent AF. EP Lab Digest EP Lab Digest breaks down the details; preview below and full story here ➡️ https://lnkd.in/gxASSJZP #eplab #cardiology #vMap #medtech #afib
-
Vektor Medical, Inc. reposted this
🙌 News 🙌 — Baptist Health System KY & IN has enrolled the first patients in the IMPRoVED-AF study. This prospective, randomized, multi-center study will evaluate the clinical benefit of using #vMap, our FDA-cleared, non-invasive arrhythmia analysis tool, to guide ablation strategies beyond PVI in patients with persistent and recurrent AF. ➡️ vMap transforms data from a standard 12-lead ECG into actionable insights that can uncover arrhythmia drivers that are often unseen. ⬅️ IMPRoVED-AF will compare outcomes in patients treated with PVI alone vs. PVI plus additional driver ablation guided by vMap. vMap works alongside all standard-of-care ablation techniques, including PFA. “For patients with persistent and recurrent AF, treatment has often been ineffective due to the inability to identify the source of the arrhythmia. Using vMap to determine a targeted ablation strategy beyond the pulmonary veins provides an opportunity to target drivers that were previously undetectable. That means better care and more effective, lasting results for patients.” — Gery Tomassoni, Principal Investigator, Baptist Health Lexington Read the entire release here: https://lnkd.in/eRVFfJ-Z 📸 Pictured below: David Krummen and Gery Tomassoni Gery Tomassoni, Kristie Schneider, Gwyn Middleton, Patrick Barry, Katie Nolan, Alex Knisely, BSBA, CCRP #cardiology #eplab #medtech #clinicaldata #PFA
-